Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Continues Showcasing Proprietary Research at Cannabis Investment Conferences

  • Proprietary Lexaria technology improves delivery of bioactive compounds in a variety of products, including cannabis-based gourmet foods
  • Market predictions for the legal marijuana industry forecast $50 billion in sales by 2026
  • 19 patent applications filed and pending in more than 40 countries

Following a successful showing at the inaugural Institutional Capital & Cannabis Conference (IC3) in California earlier this month, Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka expects the company to be noticed by investors. Bunka’s presentation of the company’s latest technology slated to benefit the cannabis industry includes the world’s first clinical study on human volunteers of cannabidiol (CBD) within Lexaria’s TurboCBD™ product.

The study, which aims to evaluate the effects of TurboCBD™ on both cardiovascular health and cognitive function, will have a double-blind and placebo controlled cross-over design measuring effects after a single dose, as well as seven days of daily dosing, in 24 volunteers (http://nnw.fm/Uh5R4).

“Results will advance Lexaria’s ability to custom design products that increase the leading performance our technology already offers to customers,” Bunka said in a press release outlining the project.

While Hurricane Irma has postponed Bunka’s next mainstream presentation, slated for the now on-hold Institutional Capital & Cannabis Conference in Miami Beach, Florida, Lexaria continues its drive to showcase the benefits of the company’s unique patented delivery technology (http://nnw.fm/e7OkE).

Lexaria researchers work to solve a critical problem facing the cannabis industry – the fact that most of the CBD and tetrahydrocannabinol (THC) that people consume, through any method, is literally flushed away in the proverbial toilet. To that end, Lexaria has focused on discovering new technologies that can more efficiently deliver cannabinoids to the bloodstream, where they can have their desired effect.

Lexaria’s patented DehydraTECH™ technology solves this problem by delivering cannabinoids in an oral form that masks any undesirable taste but increases bioabsorption, speed of effectiveness and potency. This method of delivery is a more viable and healthier method than smoking or vaping cannabis, a route that non-users and medical providers frown upon due to documented health concerns.

Marijuana is now legal in some form in 29 states and Canada. In fact, the Canadian government is expected to legalize adult use of cannabis in 2018, and there are growing movements in the U.S. to legalize cannabis nationwide, as well. Industry experts predict that U.S. retail sales alone could reach $50 billion by 2026 (http://nnw.fm/0mG2S).

For more information, visit the company’s website at www.LexariaEnergy.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s